Compare KXIN & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KXIN | TNON |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | China | United States |
| Employees | 13 | 27 |
| Industry | Retail-Auto Dealers and Gas Stations | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 7.6M |
| IPO Year | N/A | N/A |
| Metric | KXIN | TNON |
|---|---|---|
| Price | $4.89 | $0.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 85.4K | 73.8K |
| Earning Date | 11-26-2019 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $65.95 |
| Revenue Next Year | N/A | $50.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.11 | $0.64 |
| 52 Week High | $22.00 | $2.48 |
| Indicator | KXIN | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 46.03 | 50.92 |
| Support Level | $0.47 | $0.76 |
| Resistance Level | $5.86 | $0.82 |
| Average True Range (ATR) | 0.45 | 0.04 |
| MACD | -0.20 | -0.00 |
| Stochastic Oscillator | 29.31 | 48.24 |
Kaixin Holdings is an auto dealership company mainly engaged in the sale of domestic and imported automobiles in China. The company provides new and used car buyers in China with access to a wide selection of used vehicles across its network of dealerships, with a focus on premium brands such as Audi, BMW, Mercedes-Benz, Land Rover, and Porsche. The company generates revenue from automobile sales and related services.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.